InvesTrust Acquires New Holdings in CVS Health Co. (NYSE:CVS)

InvesTrust purchased a new stake in CVS Health Co. (NYSE:CVS) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 40,815 shares of the pharmacy operator’s stock, valued at approximately $1,823,000.

A number of other hedge funds also recently made changes to their positions in the business. MidAtlantic Capital Management Inc. acquired a new position in CVS Health during the 3rd quarter worth $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health in the third quarter worth about $31,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC acquired a new position in CVS Health during the 3rd quarter valued at about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health in the 3rd quarter worth approximately $33,000. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several recent analyst reports. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Barclays dropped their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Mizuho lowered their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. UBS Group upped their price target on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Finally, Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Stock Up 0.3 %

Shares of NYSE CVS traded up $0.12 during mid-day trading on Wednesday, reaching $45.90. The company had a trading volume of 7,476,451 shares, compared to its average volume of 11,352,654. The stock has a fifty day moving average of $52.40 and a two-hundred day moving average of $56.86. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $81.03. The company has a market capitalization of $57.76 billion, a price-to-earnings ratio of 11.65, a PEG ratio of 0.85 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the company posted $2.21 EPS. As a group, equities research analysts expect that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 5.80%. CVS Health’s payout ratio is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.